Oncotrace™
Supporting Your
Cancer Monitoring Journey
Oncotrace™
Whether you're undergoing treatment or have completed it, one question remains the same:
HOW IS YOUR CANCER CHANGING OVER TIME?
Through a simple blood draw, Oncotrace looks for cancer cells that have broken away from the main tumour and entered your bloodstream.
Changes in your cancer biology over time
How your cancer may be responding to treatment
Whether cancer cells show signs that may be consistent with treatment resistance
Whether results are consistent with biological remission
Whether results may provide additional information relevant to recurrence assessment
What Exactly Is Oncotrace
CTC Count
The number of circulating tumour cells found in your blood, tracked across repeat tests over time.
Phenotype Markers
Information about where the cancer cells may have originated, and certain characteristics of how they behave.
Stemness Markers
Information related to cancer stem cell activity, which may provide relevant context alongside CTC count.
What This Means for Your Treatment – Oncotrace does not replace scans, standard monitoring, or your medical team’s judgement. It provides additional biological information that may support their overall assessment. As a repeatable blood test, it may also provide more frequent data between regular appointments.
Why "Stable" Doesn't Always Mean "Unchanging"
Cancer monitoring often relies on periodic snapshots — a scan every few weeks or months, a result described as “stable,” “improving,” or “progressing.”
Scans
Show structure — size, location, visible changes
Oncotrace
Tracks circulating tumour cells through repeat blood draws, which can be done more often than imaging — adding data points in the gaps between your appointments
Three Things Oncotrace Tracks Over Time
CTC Count -
How Many Cancer Cells Were Found?
The number of circulating tumour cells found in your blood sample. Changes in this count over time may provide additional biological information about how your cancer is changing, giving your medical team another piece of information to consider alongside imaging, blood tests and other clinical findings.
Phenotype Markers -
What Characteristics Do These Cancer Cells Have?
Phenotype markers look at the biological characteristics of the circulating tumour cells, helping identify what type of cells they are and how they may behave. This provides additional biological information that may help your medical team build a broader understanding of your cancer.
Stemness Markers -
What More Can These Cells Tell Us?
These relate to biological activity associated with cancer stem cells, studied because they may influence how cancer responds to treatment — examples include SOX2, NANOG and OCT4. Understanding these markers may provide additional biological information to help your medical team build a more complete picture of your cancer.
Your Trend Is What Matters — Not a Single Result
Think of it like two people who wear the same shoe size but don’t have the same feet. The shoe size tells you where to start — it doesn’t guarantee the fit.
Your first test establishes a baseline
Each test after that is compared against your own history, not against other patients or a general population — because these biological markers may change differently from one person to another over time.
WHY IS THIS IMPORTANT
Tracking these changes over time may provide additional biological information to support discussions about whether treatment appears to be working — how often testing repeats is determined by your medical team based on your situation.
What This Means for Your Treatment
Getting Started Is
Simpler Than You Think
Talk to Us
Tell us about your situation.
We will help you understand how Oncotrace may support your cancer monitoring and answer general questions about the process.
We Support Your Doctor Conversation
We provide educational resources about Oncotrace that you can share with your doctor — supporting a more informed discussion about your results and overall care.
We Handle the Coordination
Oritov coordinates the referral with a registered partner clinic in Singapore.
You focus on your health — we handle the rest.
A Simple Blood Draw
A blood sample is collected at a registered clinic by a qualified medical professional.
Repeat blood draws may be used to track Oncotrace markers over time.
Your Medical Team Receives the Report
Your laboratory report goes directly to your medical team.
Oritov provides educational support to help you and your doctor understand the biological information and discuss what the results may mean over time.
CONTINUE EXPLORING
Continue Your Journey
Supporting Your Cancer Monitoring, One Pattern at a Time
FREQUENTLY ASKED QUESTIONS
Does Oncotrace™ need to be taken more than once?
Yes — Oncotrace™ is designed to be repeated over time. Your first test establishes a baseline, and each test after that is compared against your own previous results, not a general population. Your medical team determines how often testing is appropriate for your individual situation.
What does Oncotrace™ actually measure?
Oncotrace™ tracks three things through a blood sample: your circulating tumour cell (CTC) count, phenotype markers, and stemness markers. Together, these are compared across repeat tests to track change over time.
Does Oncotrace replace scans or imaging?
No. Oncotrace™ and scans look at different things on different schedules. Scans show structure — size, location, and visible changes. Oncotrace™ tracks circulating tumour cells through repeat blood draws. Neither replaces the other — together, they provide complementary information that your medical team may consider alongside other clinical findings over time.
How much does Oncotrace™ cost?
The cost of Oncotrace™ depends on your individual circumstances and any associated clinical arrangements. Our team can explain current pricing and what is included during your initial discussion.
Why would my medical team want more frequent monitoring, if scans are already part of my care?
A single result — high, low, or in between — is just one number, and several results across repeat tests can show whether things are holding steady or moving in a direction over time. This isn’t a sign that your current monitoring is incomplete — periodic testing is standard for good reason, and that’s true for every patient. If this kind of pattern-tracking could be useful for your specific situation, that’s a question worth bringing to your medical team, or to us.
